uMotif and ClinOne announced at the 2022 DIA Global Annual Meeting that they have partnered to deliver an integrated solution for eCOA and eConsent in trials
A leader from the clinical trial technology company says that insights gained during the recent pandemic could be helpful in realizing future improvements.
TeleConsent empowers trial teams to obtain informed consent and re-consent from patients participating in clinical studies, within a fully remote system.
Signant Health is piloting the use of eConsent in a ‘landmark’ study in China, the successful completion of which will encourage further adoption of the technology across the Asia Pacific region, says VP.
CRF Bracket – newly-rebranded as Signant Health – is looking to build momentum around eConsent, rethink the patient’s connection to the supply chain, and build out a stronger analytics platform, says CEO.
The industry has advanced to a point that should justify the financial investment in new technology, though uncertainty, and a lack of support, are hindering movement.
Iqvia describes the new platform as the marriage of eConsent with an authoring system – giving the clinical trial a framework for transparency and transformational change.
Medrio’s FDA-compliant tablet-based electronic-consent application for clinical trial participants looks to improve comprehension with graphics and videos.
Genstar Capital, the private equity firm behind Bracket, has purchased CRF Health in a deal that will create a combined organization with more than 1,500 employees globally.
